1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. ZENAS BIOPHARMA INC.
Zenas Biopharma Inc. XNAS: ZBIO
12.35 -0.47 (-3.67%)
298.8K
XNAS Volume

XNAS 15 Jul, 2025 5:30 PM (EDT)



Insider Trading disclosures for Zenas Biopharma Inc.

The latest disclosure was made by Joseph Farmer in Zenas Biopharma Inc. where a trade of 175,000 Stock Option (Right to Buy) done was reported to US exchanges on June 10, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Joseph Farmer See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 175,000 175,000 - - Stock Option (Right to Buy)
Leon Oliver Moulder Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 400,000 400,000 - - Stock Option (Right to Buy)
Patricia L. Allen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 18,500 18,500 - - Stock Option (Right to Buy)
Patrick G. Enright Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 18,500 18,500 - - Stock Option (Right to Buy)
Jake R. Nunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 18,500 18,500 - - Stock Option (Right to Buy)
John J. Orloff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 18,500 18,500 - - Stock Option (Right to Buy)
Orlando Oliveira See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 100,000 100,000 - - Stock Option (Right to Buy)
Hongbo Lu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 18,500 18,500 - - Stock Option (Right to Buy)
Jennifer A. Fox See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 150,000 150,000 - - Stock Option (Right to Buy)
James P. Boylan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2025 18,500 18,500 - - Stock Option (Right to Buy)
Lisa von Moltke See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2025 400,000 400,000 - - Stock Option (Right to Buy)
Oliver Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 6.67 per share. 18 Feb 2025 25,000 266,155 - 6.7 166,750 Common Stock
Ting Xiao Director Purchase of securities on an exchange or from another person at price $ 7.76 per share. 07 Feb 2025 10,000 47,000 - 7.8 77,600 Common Stock
Ting Xiao Director 07 Feb 2025 10,000 10,000 - 7.8 77,600 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures